Takashi Kojima

Summary

Affiliation: Pharmaceutical Research Division
Country: Japan

Publications

  1. ncbi High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate
    Takashi Kojima
    Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, Yodogawa ku, Osaka, Japan
    Int J Pharm 399:52-9. 2010
  2. ncbi Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties
    Shunichirou Tsutsumi
    Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 2 17 85 Jusohonmachi, Yodogawa ku, Osaka 532 8686, Japan
    Int J Pharm 421:230-6. 2011

Collaborators

  • Yukihiro Ikeda
  • Shunichirou Tsutsumi
  • Motoo Iida
  • Kunikazu Moribe
  • Kenjirou Higashi
  • Keiji Yamamoto
  • Norio Tada
  • Toshiya Moriwaki

Detail Information

Publications2

  1. ncbi High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate
    Takashi Kojima
    Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, Yodogawa ku, Osaka, Japan
    Int J Pharm 399:52-9. 2010
    ..Information obtained in this screening allows effective solid form selection by saving cost and time for the development...
  2. ncbi Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties
    Shunichirou Tsutsumi
    Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 2 17 85 Jusohonmachi, Yodogawa ku, Osaka 532 8686, Japan
    Int J Pharm 421:230-6. 2011
    ..e., a Michael adduct, between miconazole and the acids. Hemisuccinate had a superior intrinsic dissolution rate and stability, and is thus considered a promising crystal form of miconazole...